Schizophrenia is a major public health problem. Affecting almost 1% of the world’s population, it takes an enormous economic and social toll in addition to the distress, dysfunction, disability and mortality for those afflicted with this disease. Elements of the disease are present from birth, other aspects emerge during developmental years, and the illness becomes fully expressed in early adulthood with long-lasting implications for most patients.
Home » Psychology news » Schizophrenia: 22nd Congress Of The European College Of Neuropsychopharmacology, Sept. 14, 2009, Istanbul, Turkey
Schizophrenia: 22nd Congress Of The European College Of Neuropsychopharmacology, Sept. 14, 2009, Istanbul, Turkey
September 16, 2009 by NewsBot


